Cargando…
Regional gray matter changes and age predict individual treatment response in Parkinson's disease
We aimed at testing the potential of biomarkers in predicting individual patient response to dopaminergic therapy for Parkinson's disease. Treatment efficacy was assessed in 30 Parkinson's disease patients as motor symptoms improvement from unmedicated to medicated state as assessed by the...
Autores principales: | Ballarini, Tommaso, Mueller, Karsten, Albrecht, Franziska, Růžička, Filip, Bezdicek, Ondrej, Růžička, Evžen, Roth, Jan, Vymazal, Josef, Jech, Robert, Schroeter, Matthias L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413309/ https://www.ncbi.nlm.nih.gov/pubmed/30558868 http://dx.doi.org/10.1016/j.nicl.2018.101636 |
Ejemplares similares
-
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
por: Ballarini, Tommaso, et al.
Publicado: (2018) -
Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease
por: Mueller, Karsten, et al.
Publicado: (2018) -
Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson’s disease
por: Mueller, Karsten, et al.
Publicado: (2020) -
Separate neural representations of depression, anxiety and apathy in Parkinson’s disease
por: Dan, Rotem, et al.
Publicado: (2017) -
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
por: Mueller, Karsten, et al.
Publicado: (2018)